Johnson Fistel Investigates IperionX After $34.8M Loss, $330M Overstatement
Johnson Fistel has launched an investigation into IperionX after the company reported a $34.8 million net loss in H1 fiscal 2026 and corrected a $330 million overstatement. Investors who purchased shares and suffered losses following the share price decline are encouraged to join potential claims under federal securities laws.
1. Investigation Launch
Johnson Fistel has initiated a probe into whether IperionX’s executive officers violated securities laws following significant financial disclosures and a subsequent share price drop.
2. Financial Results
In the first half of fiscal 2026, IperionX reported a net loss of $34.8 million, more than double the $16.2 million loss recorded in the same period a year earlier.
3. Restatement Details
A day after releasing H1 results, the company corrected a typographical error that had overstated certain figures by approximately $330 million, triggering investor concerns and a sell-off.
4. Potential Investor Claims
Shareholders who purchased IperionX securities and incurred losses after these disclosures are being invited to participate in potential legal action to recover their investments.